Understanding the Half-Life Extension of Intravitreally Administered Antibodies Binding to Ocular Albumin
The burden associated with frequent injections of current intravitreal (IVT) therapeutics may be reduced by long-acting delivery strategies. Binding to serum albumin has been shown to extend the ocular half-life in rabbits, however, the underlying molecular mechanisms and translational relevance rem...
Main Authors: | Simon Hauri, Paulina Jakubiak, Matthias Fueth, Stefan Dengl, Sara Belli, Rubén Alvarez-Sánchez, Antonello Caruso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/9/810 |
Similar Items
-
Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®
by: Sven Hoefman, et al.
Published: (2015-07-01) -
Comparative Study of Ocular Pharmacokinetics of Topical 0.3% Gatifloxacin Eye Gel and Solution in Rabbits
by: Manli Liu, et al.
Published: (2022-04-01) -
Plasma disappearance rate of albumin when infused as a 20% solution
by: Markus Zdolsek, et al.
Published: (2022-04-01) -
Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species
by: Michiel M. Harmsen, et al.
Published: (2024-01-01) -
Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization in vitro and in vivo
by: Jieran Shi, et al.
Published: (2023-07-01)